NCT00220155 Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00220116 Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00217711 Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00216424 Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma Status TERMINATED Phase PHASE4
NCT00215982 Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00210106 Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. Status COMPLETED Phase NA
NCT00209742 Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT00209703 Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00209651 Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00209625 Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00208546 Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00208260 Intensified Chemotherapy in CRC After Resection of Liver Metastases Status COMPLETED Phase PHASE2/PHASE3
NCT00207051 BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies Status COMPLETED Phase PHASE1
NCT00203411 Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00202787 Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00202774 Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00199862 Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer Status COMPLETED Phase NA
NCT00199797 Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1